MN’s Bioanalysis portfolio includes trusted solutions for RNA, DNA, and protein purification from a wide range of sample types and formats. Backed by in-house R&D and German manufacturing, MN products are recognised for their precision, reliability, and scientific excellence.
Researchers have long paired MN’s extraction and purification kits with our downstream tools like PCR and NGS, and with great success,” commented Caroline Cousquer, Head of Marketing, EMEA at Takara Bio Europe. “This partnership gives scientists even more confidence in their workflow.”
“We have long admired the quality of support and expertise Takara Bio Europe brings to the scientific community,” says Peter Kuckenberg, Director International Sales at MN. “This collaboration is a natural fit, and we’re excited to see our technologies reach more researchers through their established network.”
About MACHEREY-NAGEL
Founded in 1911, MACHEREY-NAGEL is a globally active company specializing in molecular biology and chemical analysis. Headquartered in Düren, Germany, the company employs over 700 staff across its main site and subsidiaries in Switzerland, France, and the United States.
MACHEREY-NAGEL offers a broad portfolio of more than 25,000 products in the areas of filtration, rapid testing, water analysis, chromatography, and bioanalysis. All products are manufactured in Germany and distributed to over 150 countries through a global network of sales teams and authorized partners.
The company is known for its high-quality standards, reliable product performance, and customer-oriented service. Continuous investment in research and development, along with state-of-the-art manufacturing, makes MACHEREY-NAGEL a trusted partner in analytical science. For more information, please visit www.mn-net.com.
About Takara Bio
Takara Bio Europe, a subsidiary of Takara Bio Inc., is a leading manufacturer and supplier of molecular and cellular research reagents and services. Their portfolio supports applications including NGS, cloning, genetic analysis, protein expression and purification, gene editing and stem cell research.
Key products include SMART NGS kits for DNA- and RNA-seq, high-performance qPCR and PCR reagents, RT enzymes, and the innovative In-Fusion® cloning system. The portfolio also features the Shasta Single-Cell System for automated single-cell sequencing and the SmartChip platform for high-throughput qPCR.
With the recent acquisition of Curio Bioscience, Takara Bio has expanded its capabilities to include spatial transcriptomics, complementing its existing expertise in NGS R&D, manufacturing, and automation solutions for NGS and qPCR applications. The company’s comprehensive portfolio supports a wide range of research areas, including NGS, gene discovery and regulation, genetic analysis, protein expression and purification, gene editing, stem cell research, and plant and food science.
For more information, visit www.takarabio.com